GlassScriptPhysician profile
Stephen B Sexson
NPI 1376535880
$4,498.53
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $82.39 · 2021: $11.60 · 2022: $1,119 · 2023: $3,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $3,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $3,118.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iq Med LLC | $4,236.50 | 2022-2023 | |
| Acumed LLC | $125.00 | 2019 | |
| Radius Health, INC. | $77.86 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $31.19 | 2019 | |
| Mallinckrodt Hospital Products INC. | $16.13 | 2020 | |
| Vericel Corporation | $11.85 | 2019 |
Research and ownership
$296,375.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sexson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.